A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery

Endocrinology

Volumn 154, Issue 7, 2013, Pages 2341-2351

  Kohli, Rohit ^a   Setchell, Kenneth D R ^a   Kirby, Michelle ^a   Myronovych, Andriy ^a   Ryan, Karen K ^b   Ibrahim, Samar H ^c   Berger, Jose ^b   Smith, Kathi ^b   Toure, Mouhamadoul ^b   Woods, Stephen C ^b   Seeley, Randy J ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CCAAT ENHANCER BINDING PROTEIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; MESSENGER RNA; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARIATRIC SURGERY; BILE ACID BLOOD LEVEL; BILE DIVERSION; BODY WEIGHT; CATHETER; COMMON BILE DUCT; CONTROLLED STUDY; DIET; ENDOPLASMIC RETICULUM STRESS; ENTEROHEPATIC CIRCULATION; FAT MASS; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; JEJUNUM; MALE; NONHUMAN; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SERUM; SHAM PROCEDURE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANIMALS; BARIATRIC SURGERY; BILE ACIDS AND SALTS; ENDOPLASMIC RETICULUM STRESS; GLUCAGON-LIKE PEPTIDE 1; MALE; OBESITY; RATS; TAUROCHENODEOXYCHOLIC ACID;

EID: 84879313530     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2069     Document Type: Article

References (35)

1. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567-1576
2. Xanthakos SA, Miles L, Bove K, Inge T. Outcome of nonalcoholic fatty liver disease (NAFLD) in adolescents after bariatric surgery. (Obesity Society Annual Meeting, New Orleans, Louisiana). Obesity (Silver Spring). 2007;15:A209.
3. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-1585
4. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752. (Pubitemid 47295641)
5. Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009;58:1400-1407.
6. Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 2009;17:1671-1677.
7. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell. 1999;3:543-553. (Pubitemid 29268438)
8. Parks DJ, Blanchard SG, Bledsoe RK, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science. 1999;284:1365-1368. (Pubitemid 29289664)
9. Cipriani S, Mencarelli A, Palladino G, Fiorucci S. FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J Lipid Res. 2010;51:771-784.
10. Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10:167-177.
11. Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484-489. (Pubitemid 43152840)
12. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89:147-191.
13. Jansen PL, van Werven J, Aarts E, et al. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery. Dig Dis. 2011;29:48-51.
14. Wu T, Bound MJ, Standfield SD, Jones KL, Horowitz M, Rayner CK. Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans. J Clin Endocrinol Metab. 2013;98:E718-E722
15. Kohli R, Kirby M, Setchell KD, et al. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol. 2010;299:G652-G660.
16. Manfredini G, Ermini M, Scopsi L, Bonaguidi F, Ferrannini E. Internal biliary diversion improves glucose tolerance in the rat. Am J Physiol. 1985;249:G519-G527. (Pubitemid 16201180)
17. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 2005;288:E447-E453. (Pubitemid 40110655)
18. Melgarejo T, Williams DA, O'Connell NC, Setchell KD. Serum unconjugated bile acids as a test for intestinal bacterial overgrowth in dogs. Dig Dis Sci. 2000;45:407-414. (Pubitemid 30133907)
19. Hagio M, Matsumoto M, Fukushima M, Hara H, Ishizuka S. Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS. J Lipid Res. 2009;50:173-180.
20. Woods SC, Seeley RJ, Rushing PA, D'Alessio D, Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr. 2003;133:1081-1087. (Pubitemid 36407129)
21. Stefater MA, Sandoval DA, Chambers AP, et al. Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology. 2011;141:939-949.e1- 4.
22. Chen YJ, Inouye M. The intramolecular chaperone-mediated protein folding. Curr Opin Struct Biol. 2008;18:765-770.
23. Yang JS, Kim JT, Jeon J, et al. Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice. PLoS One. 2010;5:e13858.
24. Kars M, Yang L, Gregor MF, et al. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes. 2010;59:1899-1905.
25. Perlow JH, Morgan MA. Massive maternal obesity and perioperative cesarean morbidity. Am J Obstet Gynecol. 1994;170:560-565. (Pubitemid 24089015)
26. Sjovall J. Dietary glycine and taurine on bile acid conjugation in man; bile acids and steroids 75. Proc Soc Exp Biol Med. 1959;100:676-678.
27. Setchell KD, Dumaswala R, Colombo C, Ronchi M. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J Biol Chem. 1988;263:16637-16644. (Pubitemid 18268842)
28. Encrantz JC, Sjovall J. On the bile acids in duodenal contents of infants and children. Bile acids and steroids 72. Clin Chim Acta. 1959;4:793-799.
29. Shonsey EM, Wheeler J, Johnson M, et al.Synthesis of bile acid coenzyme a thioesters in the amino acid conjugation of bile acids. Methods Enzymol. 2005;400:360-373. (Pubitemid 43052431)
30. Stroeve JH, Brufau G, Stellaard F, Gonzalez FJ, Staels B, Kuipers F. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Lab Invest. 2010;90:1457-1467.
31. Sinha J, Chen F, Miloh T, Burns RC, Yu Z, Shneider BL. β-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. Am J Physiol Gastrointest Liver Physiol. 2008;295:G996-G1003.
32. Potthoff MJ, Boney-Montoya J, Choi M, et al. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway. Cell Metab. 2011;13:729-738.
33. Chen L, Yao X, Young A, et al. Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes. Am J Physiol Endocrinol Metab. 2012;302:E68-E76.
34. Holzbach RT. Hepatic effects of jejunoileal bypass for morbid obesity. Am J Clin Nutr. 1977;30:43-52. (Pubitemid 8054121)
35. Moxley RT, 3rd, Pozefsky T, Lockwood DH. Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N Engl J Med. 1974;290:921-926. and Kidney Diseases/National Institutes of Health Kidney Diseases/National Institutes of Health